PRECLINICAL JUSTIFICATION OF PBI-SHRNA EWS/FLI1 LIPOPLEX (LPX) TREATMENT FOR EWING’S SARCOMA
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing’s Sarcoma. Molecular Therapy. 2016 Aug; 24(8):1412-22.
THREE YEAR FOLLOW UP OF GMCSF/BI-SHRNA FURIN DNA TRANSFECTED AUTOLOGOUS TUMOR IMMUNOTHERAPY (VIGIL™) IN METASTATIC ADVANCED EWING’S SARCOMA
Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing’s Sarcoma. Molecular Therapy.
ABC DFW: IMMUNOTHERAPY BOOSTS BODY’S DEFENSE
Grandmother with cancer battles the odds with new immunotherapy clinical trial.
MARY CROWLEY QUARTERLY: VOLUME 6 ISSUE 2
MARY CROWLEY QUARTERLY: VOLUME 6 ISSUE 1
HOW CANCER WILL AFFECT AMERICANS IN 2016
Here’s the good news about cancer in America: More people than ever are surviving it.
CBS DFW NEWS STORY: IMMUNOTHERAPY CANCER RESEARCH
Immunotherapy Program at Mary Crowley Cancer Research provides hope to cancer patients.
SOUTHWEST AIRLINES TECHNOLOGY “LUVS” MARY CROWLEY!
The 17th Annual Southwest Airlines Technology Classic Car Show has raised $21,000 for Mary Crowley Cancer Research.
MARY CROWLEY QUARTERLY: VOLUME 5 ISSUE 4
HOCKEY FIGHTS CANCER 2015
Team partners with Dallas-area cancer-fighting organizations to raise funds for cancer research and support programs at the annual Hockey Fights Cancer event.